Daniel R. Goldberg - Concepedia

Author

Daniel R. Goldberg

Boehringer Ingelheim (United States)ORCID

Also Known As

D. Goldberg, D. R. GOLDBERG, D.R. Goldberg, Daniel E. Goldberg, Daniel Goldberg, Daniel R Goldberg, Daniel R. Goldberg, Kavita Nanda

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (United States)Vion Pharmaceuticals (United States)Cayman Chemical (United States)Boehringer Ingelheim (France)Boehringer Ingelheim (Japan)

About

Daniel R. Goldberg is an author at Boehringer Ingelheim (United States) specializing in drug discovery, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	361
2	Biochemistry	11	11	508
3	Natural Sciences	9	9	458
4	Engineering	5	5	334
5	Biomolecular Engineering	3	3	227

Daniel R. Goldberg

Publications

918

Citations

H-Index

Page 1

	Year	Citations
Acrylonitrile Cross-Metathesis: Coaxing Olefin Metathesis Reactivity from a Reluctant Substrate William E. Crowe, Daniel R. Goldberg Journal of the American Chemical Society Cross-coupling ReactionMolecular SciencesEngineeringAlkene MetathesisBiochemistry	1995	185
Preparation of allylsilanes via cross-metathesis William E. Crowe, Daniel R. Goldberg, Zhijia J. Zhang Tetrahedron Letters Organic ChemistryAlkene MetathesisEnantioselective SynthesisChemistry	1996	108
Positive Cooperativity of Product Mimics in the Asymmetric Autoinduction of Diels−Alder Reactions Catalyzed by a VAPOL−Aluminum Catalyst Douglas P. Heller, Daniel R. Goldberg, William D. Wulff Journal of the American Chemical Society Chemical EngineeringCross-coupling ReactionEngineeringChemical ReactionsVapol−aluminum Catalyst	1997	94
The discovery of carboline analogs as potent MAPKAP-K2 inhibitors Jiang‐Ping Wu, Ji Wang, Asitha Abeywardane, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacological Agent	2007	58
Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension Robert J. Aiello, Patricia-Ann K. Bourassa, Qing Zhang, Journal of Pharmacology and Experimental Therapeutics	2016	57
Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK) Charles L. Cywin, Baoping Zhao, Daniel W. McNeil, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryDrug TargetBiochemistryNatural Sciences	2003	48
Optimization of 2-Phenylaminoimidazo[4,5-<i>h</i>]isoquinolin-9-ones: Orally Active Inhibitors of lck Kinase Daniel R. Goldberg, Tanja Butz, Mario Cardozo, Journal of Medicinal Chemistry Pharmaceutical ScienceImmunologyCell DeathImmunologic MechanismImmunotherapy	2003	45
Fragment-Based Discovery of Indole Inhibitors of Matrix Metalloproteinase-13 Steven J. Taylor, Asitha Abeywardane, Shuang Liang, Journal of Medicinal Chemistry Matrix MetalloproteasesMolecular BiologyIndole InhibitorsChemical BiologyMusculoskeletal Research	2011	45
Synthesis and SAR studies of indole-based MK2 inhibitors Zhaoming Xiong, Donghong A. Gao, Derek A. Cogan, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineIndole-based Mk2 InhibitorsDrug DevelopmentPharmacology	2008	38
Second-Generation Lymphocyte Function-Associated Antigen-1 Inhibitors: 1<i>H</i>-Imidazo[1,2-α]imidazol-2-one Derivatives Jiang‐Ping Wu, Jonathan Emeigh, Donghong A. Gao, Journal of Medicinal Chemistry	2004	34

Page 1